Merck Sharp and Dohme Corp. Mergers and Acquisitions


Merck Sharp and Dohme Corp.

One Merck Drive
Whitehouse Station, NJ 08889-3400
United States
Tel:1/908 423-1000
URL: http://www.merck.com
Formerly known as:
Merck & Company, Inc.
Industry:
Pharmaceutical
Merck Sharp and Dohme Corp. Company Snapshot

Merck Sharp and Dohme Corp. Deal Timeline


Drag the timeline to see more deals; click on a deal to see details.


Acquisitions > 100 M$ 10 to 100 M$ < 10M$ Stakes Divestitures

Merck Sharp and Dohme Corp. M&A History


Sanofi-Aventis SA acquires remaining interest in Merial Ltd from Merck & Co Inc Sanofi-Aventis SA acquires remaining interest in  Merial Ltd from Merck & Co IncSep 18, 2009

US - Sanofi-Aventis SA (Sanofi-Aventis) of France acquired the remaining ##% interest, which it did not already own, in Merial Ltd, a Duluth-based manufacturer of animal vaccines, from joint venture partner Merck & Co Inc (Merck), for USD #

Taiho Pharmaceutical Co Ltd acquires Banyu-Tsukuba Labo from Merck & Co Inc Taiho Pharmaceutical Co Ltd acquires  Banyu-Tsukuba Labo from Merck & Co IncAug 31, 2009

JAPAN - Taiho Pharmaceutical Co Ltd, a wholly owned subsidiary of Otsuka Holdings Co Ltd, acquired a part of the Tsukuba laboratory of Banyu Pharmaceutical Co Ltd, a Tsukuba, Ibaraki-based developer and wholesaler of pharmaceutical products and a wholly owned

Mediolanum Farmaceutici-SPV acquires Neopharmed Srl from Merck & Co Inc Mediolanum Farmaceutici-SPV acquires  Neopharmed Srl from Merck & Co IncAug 11, 2009

ITALY - Mediolanum Farmaceutici SpA (MF), through a special purpose vehicle, acquired the entire share capital of Neopharmed Srl a Rome-based company that manufactures and wholesales prescription pharmaceuticals. Concurrently, MF acquired the entire share capital of Istituto Gentili SpA.

Mediolanum Farmaceutici-SPV acquires Istituto Gentili SpA from Merck & Co Inc Mediolanum Farmaceutici-SPV acquires  Istituto Gentili SpA from Merck & Co IncAug 11, 2009

ITALY - Mediolanum Farmaceutici SpA, through a special purpose vehicle, acquired the entire share capital of Istituto Gentili SpA, a Rome-based company that manufactures and wholesales prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics. At the same

Covance Inc acquires Gene Expression Laboratory from Merck & Co Inc (pending) Covance Inc acquires  Gene Expression Laboratory from Merck & Co Inc (pending)Jul 30, 2009

US - Covance inc agreed to acquire Gene Expressions Laboratory, a Seattle-based provider of genomics services, from Merck & Co Inc.

Intervet/Schering-Plough acquires Merial Ltd from Merck & Co Inc (pending) Intervet/Schering-Plough  acquires  Merial Ltd from Merck & Co Inc (pending)Jul 30, 2009

US - Intervet/Schering-Plough Animal Health of the Netherlands, a unit of Schering-Plough Corp, planned to merge with Merial Ltd, a Duluth-based manufacturer of animal vaccines, and a joint venture between Merck & Co Inc and Merieux International SA

ROVI Imaging SL acquires Frosst Iberica SA from Merck & Co Inc (pending) ROVI Imaging SL acquires  Frosst Iberica SA from Merck & Co Inc (pending)Jul 24, 2009

SPAIN ? ROVI Imaging SL, a wholly-owned unit of Inversiones Clidia SL?s Laboratorios Farmaceuticos Rovi SA {ROVI} subsidiary, agreed to acquire Frosst Iberica SA, an Alcala de Henares-based manufacturer of pharmaceutical products, from Merck Sharp & Dohme BV, a

Merck & Co Inc seeking buyer for Merck & Co-Animal-Health Bus Merck & Co Inc seeking buyer for Merck & Co-Animal-Health BusJun 03, 2009

US - In June ####, Merck & Co Inc, a Whitehouse Station- based manufacturer and developer of pharmaceutical products, announced that it was seeking a buyer for its animal-health business unit. Sanofi-Aventis SA, Novartis AG, Bauer AG, Eli Lilly & Co

Microsoft Corp acquires Rosetta Biosoftware from Merck & Co Inc (pending) Microsoft Corp acquires Rosetta Biosoftware from Merck & Co Inc (pending)Jun 01, 2009

US - Microsoft Corp planned to acquire Rosetta Biosoftware, a developer of bioinformatics software, from Rosetta Inpharmatics LLC, a unit of Merck & Co Inc. Terms were not disclosed.

Merck & Co Inc seeking buyer for IRBM P. Angeletti Merck & Co Inc seeking buyer for IRBM P. AngelettiApr 24, 2009

ITALY - In April ####, Instituto di Ricerche di Biologia Molecolare P. Angeletti, a unit of Merck & Co Inc, announced that it was seeking a buyer for the company.

Merck & Co Inc acquires Insmed Inc-Comml Mnfg from Insmed Inc Merck & Co Inc acquires Insmed Inc-Comml Mnfg from Insmed IncMar 31, 2009

US - Merck & Co Inc acquired the commercial manufacturing facilities, located in Boulder, Colorado, of Insmed Inc, a manufacturer of pharmaceutical products, for $### mil in cash.

Merck & Co Inc acquires Schering-Plough Corp (pending) Merck & Co Inc acquires Schering-Plough Corp (pending)Mar 09, 2009

US - Merck & Co Inc (MC) definitively agreed to acquire all the outstanding common stock of Schering- Plough Corp (SP), a manufacturer and developer of pharmaceuticals, in a stock swap transaction valued at $##.### bil. MC offered $##.# in

PPD Inc acquires Merck & Co Inc-Testing Lab from Merck & Co Inc PPD Inc acquires Merck & Co Inc-Testing Lab from Merck & Co IncJan 05, 2009

US - Pharmaceutical Product Development Inc acquired the vaccine testing laboratory of Merck & Co Inc, a manufacturer and developer of pharmaceuticals.

OBS Pakistan Private Ltd acquires MSD Pakistan from Merck & Co Inc OBS Pakistan Private Ltd acquires MSD Pakistan from Merck & Co IncApr 18, 2008

PAKISTAN - OBS Pakistan Private Ltd acquired Merck Sharp & Dohme Pakistan, a pharmaceuticals manufacturer, from Merck & Co Inc. Terms were not disclosed.

Iroko Pharmaceuticals LLC acquires Merck & Co Inc-Aggrastat from Merck & Co Inc Iroko Pharmaceuticals LLC acquires Merck & Co Inc-Aggrastat from Merck & Co IncJan 30, 2008

US - Iroko Pharmaceuticals LLC acquired the Aggrastat cardiovascular product of Merck & Co Inc, a manufacturer and developer of pharmaceuticals. Terms were not disclosed.

PRWT Services Inc acquires Merck & Co Inc-Chem Mnfr Plant from Merck & Co Inc PRWT Services Inc acquires Merck & Co Inc-Chem Mnfr Plant from Merck & Co IncJan 01, 2008

US - PWRT Services Inc acquired the Cherokee manufacturing plant, located in Riverside, Pennsylvania, of Merch & Co Inc, a manufacturer of products and antibiotics for humans and animals.

Merck & Co Inc acquires a minority stake in GTx Inc (pending) Merck & Co Inc acquires a minority stake in GTx Inc (pending)Nov 06, 2007

US - Merck & Co Inc agreed to acquire a #.##% stake, or #.### mil common shares, in GTx Inc, a biotechnology company, for $##.## per share, or a total value of $## mil, in a privately negotiated transaction

Merck & Co Inc acquires NovaCardia Inc Merck & Co Inc acquires NovaCardia IncSep 11, 2007

US - Merck & Co Inc (MC) acquired all the outstanding stock of NovaCardia Inc, a manufacturer and wholesaler of pharmaceuticals, for $###.# mil. The consideration consisted of $##.# mil in cash and $### mil in MC common shares. The

Huvepharma Inc acquires Merial Ltd-St Louis Blending from Merck & Co Inc Huvepharma Inc acquires Merial Ltd-St Louis Blending from Merck & Co IncApr 27, 2007

US - Huvepharma Inc acquired the St Louis blending facility of Merial Ltd, a manufacturer of animal vaccines, from a joint venture between Merck & Co Inc and Merieux International SA, for $## mil.

Iroko Pharmaceuticals LLC acquires Merck & Co Inc-Prescription from Merck & Co Inc Iroko Pharmaceuticals LLC acquires Merck & Co Inc-Prescription from Merck & Co IncMar 26, 2007

US - Iroko Pharmaceutical LLC acquired # prescription pharmaceutical products of Merck & Co Inc (MC), a manufacturer, developer and marketer of pharmaceutical vaccines and medicines. Terms were not disclosed. The transaction included the Indocin and Aldomet products of MC.

Merck Sharp and Dohme Corp. M&A Summary


Merck Sharp and Dohme Corp. has made 28 acquisitions while taking stakes in 7 companies. Merck Sharp and Dohme Corp. has 39 divestitures during this period.
YearAcquisitionsStakesDivestitures
2009105
2008003
2007103
2006301
2005004
2004213
2003124
2002201
2001111
2000100
1999100
1998102
1997202
1996100
1995103
1994202
1993111
1992000
1991200
1990100
1989101
1988011
1987100
1986200
1985002
1984010
Total28739

Other Recent M&A in the Pharmaceutical industry